Trials / Completed
CompletedNCT02274610
Pharmacokinetic Study of Docetaxel-PNP and Taxotere to Treat Patient With Advanced Solid Cancer
Phase I Trial to Compare Pharmacokinetics and Safety of Docetaxel PNP With Taxotere in Subjects With Advanced Solid Tumor
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Samyang Biopharmaceuticals Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of the pharmacokinetic equivalence of two Docetaxel formulations in terms of AUC and Cmax
Detailed description
Comparison of pharmacokinetic parameters (T1/2β, CL, Vdss) Safety as measured by adverse events
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Docetaxel-PNP | Docetaxel Polymeric Nanoparticle Formulation |
| DRUG | Taxotere | Docetaxel |
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2015-11-01
- Completion
- 2015-12-01
- First posted
- 2014-10-24
- Last updated
- 2017-05-01
Source: ClinicalTrials.gov record NCT02274610. Inclusion in this directory is not an endorsement.